Does EVEROLIMUS Cause Carcinoembryonic antigen increased? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Carcinoembryonic antigen increased have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.1% of all adverse event reports for EVEROLIMUS.
36
Reports of Carcinoembryonic antigen increased with EVEROLIMUS
0.1%
of all EVEROLIMUS reports
6
Deaths
7
Hospitalizations
How Dangerous Is Carcinoembryonic antigen increased From EVEROLIMUS?
Of the 36 reports, 6 (16.7%) resulted in death, 7 (19.4%) required hospitalization.
Is Carcinoembryonic antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Carcinoembryonic antigen increased?
RIBOCICLIB (143)
LETROZOLE (115)
CAPECITABINE (113)
FULVESTRANT (105)
BEVACIZUMAB (102)
REGORAFENIB (91)
OXALIPLATIN (88)
OSIMERTINIB (82)
PALBOCICLIB (78)
FLUOROURACIL (71)
Which EVEROLIMUS Alternatives Have Lower Carcinoembryonic antigen increased Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE